271 related articles for article (PubMed ID: 21744352)
1. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
3. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.
Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125
[TBL] [Abstract][Full Text] [Related]
4. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 7 is a predictive marker for survival in patients with esophageal squamous cell carcinoma.
Oue N; Noguchi T; Anami K; Kitano S; Sakamoto N; Sentani K; Uraoka N; Aoyagi K; Yoshida T; Sasaki H; Yasui W
Ann Surg Oncol; 2012 Jun; 19(6):1902-10. PubMed ID: 22203179
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma.
Kim HS; Won KY; Kim GY; Kim SC; Park YK; Kim YW
Pathol Res Pract; 2012 May; 208(5):292-9. PubMed ID: 22464151
[TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
11. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
13. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
[TBL] [Abstract][Full Text] [Related]
15. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.
Makino T; Yamasaki M; Takemasa I; Takeno A; Nakamura Y; Miyata H; Takiguchi S; Fujiwara Y; Matsuura N; Mori M; Doki Y
Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
[TBL] [Abstract][Full Text] [Related]
17. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.
Wang BY; Liu CY; Lin CH; Hsu PK; Hsu WH; Wu YC; Cheng CY
Ann Surg Oncol; 2012 Jul; 19(7):2149-58. PubMed ID: 22407313
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma.
Li K; Wang RW; Jiang YG; Zou YB; Guo W
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]